Inaugural Members of the Akadeum CDMO Alliance: ElevateBio (R) and Charles River. Akadeum has collaborated with both CDMOs, establishing strong data sets demonstrating reduced impurities and high ...

AstraZeneca advances haematology and cell therapy ambition with largest-ever presence at ASH: Cambridge, UK Friday, December 5, 2025, 10:00 Hrs [IST] AstraZeneca, a global, scienc ...

Rivers isn’t just the best fit possible at this point of the season, his unconventional return to the NFL is pure poetry.

Artificial intelligence, or AI, is here and is seemingly here to stay. Gov. Brad Little has proclaimed this week, Dec. 8-14, ...

Explore West Palm Beach’s essential bucket-list experiences, from waterfront views and arts to cultural landmarks and hidden ...

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

Overall response rate (ORR) in triple combo study with azacitidine and venetoclax in newly diagnosed AML patients 80% CR and 90% Composite ...

The newly formed Stop ECT Coalition, representing hundreds of thousands of individuals, has launched a nationwide campaign urging review of the ...

New research lays out just how widespread UPFs have become — and what that shift means for long-term health. Stacey Leasca is an award-winning journalist with nearly two decades of newsroom experience ...

For years, we’ve been bombarded by the trope of aging gracefully—staying small, moving slowly, playing it safe in the gym and in life. But a growing number of women are rejecting that tired script and ...

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...

The broad healthcare sector accounts for roughly one-fifth of the U.S. economy and continues to expand. While most attention ...